Probiotics for prevention of atopy and food hypersensitivity in early childhood A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials

Medicine (United States)

Volumn 95, Issue 8, 2016, Pages

  Zhang, Guo Qiang ^a   Hu, Hua Jian ^a   Liu, Chuan Yang ^a   Zhang, Qiao ^a   Shakya, Shristi ^a   Li, Zhong Yue ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; FOOD ALLERGEN; IMMUNOGLOBULIN E; PROBIOTIC AGENT;

ATOPY; BIFIDOBACTERIUM; CHILDHOOD; CONTROLLED CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; FOLLOW UP; FOOD ALLERGY; HUMAN; INFANCY; INFANT; INTESTINE FLORA; LACTOBACILLUS; META ANALYSIS; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIZATION; SYSTEMATIC REVIEW; TREATMENT DURATION; CHILD; FEMALE; FOOD HYPERSENSITIVITY; HYPERSENSITIVITY; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY; INFANT; PREGNANCY; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84962497489     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002562     Document Type: Review

References (68)

1. Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251-1258.
2. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733-743.
3. Warner JO, Kaliner MA, Crisci CD, et al. Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol. 2006;139:166-174.
4. Strachan DP. Hay fever, hygiene, and household size. Br Med J. 1989;299:1259-1260.
5. Okada H, Kuhn C, Feillet H, et al. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol. 2010;160:1-9.
6. Wold AE. The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy. 1998;53:20-25.
7. Joint FAO-WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Guidelines for the Evaluation of Probiotics in Food. London, Canada: Joint FAO/WHO Working Group Report; 2002. Available at: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
8. Bjorksten B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001;108:516-520.
9. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159:1739-1745.
10. Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 2012;129:434-440.
11. Wang M, Karlsson C, Olsson C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol. 2008;121:129-134.
12. Frei R, Akdis M, O'Mahony L. Prebioitcs, probiotics, synbioitcs, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol. 2015;31:153-158.
13. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65-W94.
14. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available at: www.cochrane-handbook.org.
15. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br Med J. 2011;343:d5928.
16. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557-560.
17. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629-634.
18. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
19. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1019-1021.
20. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869-1871.
21. Prescott SL, Wiltschut J, Taylor A, et al. Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy. 2008;63:1481-1490.
22. Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42:1071-1079.
23. Jensen MP, Meldrum S, Taylor AL, et al. Early probiotic supplementation for allergy prevention: long-term outcomes. J Allergy Clin Immunol. 2012;130:1209-1211.
24. West CE, Hammarstrom ML, Hernell O. Probiotics in primary prevention of allergic disease: follow-up at 8-9 years of age. Allergy. 2013;68:1015-1020.
25. Abrahamsson TR, Jakobsson T, Bjorksten B, et al. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol. 2013;24:556-561.
26. Loo EX, Llanora GV, Lu Q, et al. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int Arch Allergy Immunol. 2014;163:25-28.
27. Gorissen DM, Rutten NB, Oostermeijer CM, et al. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. the PANDA study. Clin Exp Allergy. 2014;44:1431-1433.
28. Allen SJ, Jordan S, Storey M, et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child. 2014;99:1014-1019.
29. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788-794.
30. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076-1079.
31. Rautava S, Kainonen E, Salminen S, et al. Maternal probiotic supplementation during pregnancy and breast-feeDing reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355-1360.
32. Huurre A, Laitinen K, Rautava S, et al. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy. 2008;38:1342-1348.
33. Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res. 2006;60:221-224.
34. Boyle RJ, Ismail IH, Kivivuori S, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011;66:509-516.
35. Kim JY, Kwon JH, Ahn SH, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21:e386-e393.
36. Kopp MV, Hennemuth I, Heinzmann A, et al. Randomized, doubleblind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850-e856.
37. Niers L, Martin R, Rijkers G, et al. The effects of selected probiotic strains on the development of eczema (the PANDA study). Allergy. 2009;64:1349-1358.
38. Soh SE, Aw M, Gerez I, et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants: effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy. 2009;39:571-578.
39. Abrahamsson TR, Jakobsson T, Bottcher MF, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174-1180.
40. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184-191.
41. Ou CY, Kuo HC, Wang L, et al. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy. 2012;42:1386-1396.
42. Dotterud CK, Storro O, Johnsen R, et al. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163:616-623.
43. West CE, Hammarstrom ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol. 2009;20:430-437.
44. Wu FL, Feng XB, Liu XX, et al. The influence of Bifidobateria on the composition of breast milk and the relationship between Bifidobacteria and the incidence of allergic diseases in breast-fed infants. J Clin Pediatr. 2010;28:260-263. (In Chinese).
45. Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema. Curr Opin Allergy Clin Immunol. 2013;13:280-286.
46. West CE, Jenmalm MC, Prescott SL. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy. 2015;45:43-53.
47. Marschan E, Kuitunen M, Kukkonen K, et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy. 2008;38:611-618.
48. Jenmalm MC, Duchén K. Timing of allergy-preventive and immunomodulatory dietary interventions: are prenatal, perinatal or postnatal strategies optimal? Clin Exp Allergy. 2013;43:273-278.
49. Fiocchi A, Pawankar R, Cuello-Garcia C, et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): probiotics. World Allergy Organ J. 2015;8:4.
50. Kuitunen M, Kukkonen K, Juntunen-Backman K, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335-341.
51. Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonization, and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63:559-566.
52. Bäckhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690-703.
53. Sanchez-Valverde F, Gil F, Martinez D, et al. The impact of caesarean delivery and type of feeDing on cow's milk allergy in infants and subsequent development of allergic march in childhood. Allergy. 2009;64:884-889.
54. Kolokotroni O, Middleton N, Gavatha M, et al. Asthma and atopy in children born by caesarean section: effect modification by family history of allergies: a population based cross-sectional study. BMC Pediatr. 2012;12:179.
55. Almqvist C, Cnattingius S, Lichtenstein P, et al. The impact of birth mode of delivery on childhood asthma and allergic diseases: a sibling study. Clin Exp Allergy. 2012;42:1369-1376.
56. Muraro A, Halken S, Arshad SH, et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy in children and adults: systemic reviews. Allergy. 2014;69:590-601.
57. Cosenza L, Nocerino R, Di Scala C, et al. Bugs for atopy: the Lactobacillus rhamnosus GG strategy for food allergy prevention and treatment in children. Benef Microbes. 2015;6:225-232.
58. Soares-Weiser K, Takwoingi Y, Panesar SS, et al. The diagnosis of food allergy: a systematic review and meta-analysis. Allergy. 2014;69:76-86.
59. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeDing might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109:119-121.
60. Sornasse T, Larenas PV, Davis KA, et al. Differentiation and stability of T helper 1 and 2 cells derived from nave human neonatal CD4 T cells, analyzed at the single-cell level. J Exp Med. 1996;184:473-483.
61. Shah A. The pathologic and clinical intersection of atopic and autoimmune disease. Curr Allergy Asthma Rep. 2012;12:520-529.
62. Yang J, Li W, Sun R, et al. The effect of Lactobacillus johnsonii Ncc533 (La1) on the balance of Th1/Th2 cells in BALB/c mice. Clin Invest Med. 2011;34:E254.
63. Matsuzaki T, Takagi A, Ikemura H, et al. Intestinal microflora: probiotics and autoimmunity. J Nutr. 2007;137:798S-802S.
64. Elazab N, Mendy A, Gasana J, et al. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics. 2013;132:e666-e676.
65. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev. 2007; CD006475.
66. Kong XY, Yang Y, Guan J, et al. Probiotics' preventive effect on pediatric food allergy: a meta-analysis of randomized controlled trials. Chin Med Sci J. 2014;29:144-147.
67. Kukkonen AK, Savilahti EM, Haahtela T, et al. Ovalbumin-specific immunoglobulins A and G levels at age 2 years are associated with the occurrence of atopic disorders. Clin Exp Allergy. 2011;41:1414-1421.
68. Berni Canani R, Nocerino R, Terrin G, et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial. J Allergy Clin Immunol. 2012;129:580-582.